Target intelligence / Profile preview

Bacterial cells and infection microenvironment

Molecular classification
Other
01

Overview

The bacterial cells and infection microenvironment represent the complex biological site where pathogenic microorganisms proliferate and interact with the host. This target is not a single molecule but a multifaceted ecosystem characterized by specific physical and chemical conditions, such as low pH, hypoxia, and the presence of bacterial enzymes or biofilms (Nature Reviews Microbiology, 2018). Therapeutic strategies often focus on the bacterial cells themselves, utilizing antibiotics that inhibit essential processes like cell wall synthesis or DNA replication (StatPearls, 2023). Modern drug delivery systems also exploit the unique characteristics of the infection microenvironment to trigger localized drug release, aiming to increase efficacy while minimizing systemic side effects (Advanced Drug Delivery Reviews, 2020). Understanding this environment is crucial for overcoming challenges like antimicrobial resistance and poor drug penetration into deep-seated infections (Journal of Clinical Investigation, 2017). Consequently, the infection microenvironment serves as both a barrier to treatment and a potential avenue for precision medicine in infectious diseases.

Other names
Pathogenic bacteriaInfected tissue microenvironmentBacterial nicheSite of infectionBacterial biofilm microenvironment
02

Mechanism of action

Inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of DNA replication, disruption of cell membrane integrity, and metabolic pathway disruption.

03

Biological functions

PathogenesisBacterial metabolismBiofilm formationHost-pathogen interactionImmune evasionQuorum sensing
04

Disease associations

InfectionSepsisAbscessBiofilm-associated infectionsChronic woundsPneumonia
05

Safety considerations

Antimicrobial resistance (AMR)Dysbiosis of commensal floraSystemic toxicityJarisch-Herxheimer reactionPoor drug penetration into biofilms
06

Interacting drugs

Amoxicillin

6 more in the full profile.

07

Biomarkers

Procalcitonin (PCT)C-reactive protein (CRP)Bacterial DNA/RNALactic acidSpecific bacterial toxins (e.g., Shiga toxin)

Beyond the preview

Go deeper on Bacterial cells and infection microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cells and infection microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call